Open AccessAbstract 5733: Versican proteolytic fragments (matrikines) synergize with STING agonists to elicit robust anti-tumor CD8+ T cell responses
Author(s) -
Athanasios Papadas,
Evan Flietner,
Zachary Morrow,
Joshua Wiesner,
Alexander Cicala,
Adam Pagenkopf,
Chelsea Hope,
Philip B. Emmerich,
Dustin A. Deming,
Jing Zhang,
Peiman Hematti,
Natalie S. Callander,
Alexander L. Rakhmilevich,
Mario Otto,
Christian M. Capitini,
Fotis Asimakopoulos
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-5733
Subject(s) - versican , tumor microenvironment , cancer research , cd8 , mhc class i , dendritic cell , chemistry , cancer immunotherapy , bone marrow , immunotherapy , immunology , immune system , biology , proteoglycan , extracellular matrix , biochemistry